SHARE
COPY LINK

VACCINE

Pfizer jab ‘probably protects’ against the Covid-19 Indian variant, says French study

The Pfizer vaccine is slightly less effective but appears to still protect against the more transmissible Indian strain of the virus that causes Covid-19, according to a study by France's Pasteur Institute.

Pfizer jab 'probably protects' against the Covid-19 Indian variant, says French study
A patient receives a dose of the Pfizer-BioNTech vaccine against the Covid-19 at the temporary Covid-19 vaccination centre at the 'Orangerie' of Versailles Palace in Versailles. (Photo by STEPHANE DE SAKUTIN / AFP)

“Despite slightly diminished efficacy, the Pfizer vaccine probably protects” against the so-called ‘Indian variant’, according to laboratory test results, said Olivier Schwartz, the institute’s director and co-author of the study that was published on the BioRxiv website ahead of peer review.   

The study sampled 28 healthcare workers in the city of Orleans. Sixteen of them had received two doses of the Pfizer vaccine, while 12 had received one dose of the AstraZeneca vaccine.

People who had received two doses of Pfizer saw a three-fold reduction in their antibodies against the Indian variant, B.1.617, according to the study, but were still protected.

READ ALSO: What is the ‘Bordeaux variant’ of Covid and should France be worried?

“The situation was different with the AstraZeneca vaccine, which induced particularly low levels of antibodies neutralising” the Indian variant, the study said.

Patients who had had Covid-19 within the past year and people vaccinated with two doses of Pfizer retained enough antibodies to be protected against the Indian variant, but three to six times less antibodies than against the UK variant, Schwartz said.

The study shows that “this variant has acquired partial resistance to antibodies,” according to Schwartz.

READ ALSO: EXPLAINED: How to book an appointment for the Covid-19 vaccine in France

Since first emerging in late 2019 in China, the SARS-CoV-2 virus that causes Covid-19 has developed several variants, usually named for the places where it first appeared including the so-called South Africa and UK strains.

The variant first detected in India appears to be much more transmissible than earlier variations.

It has now been officially recorded in 53 territories, according to a World Health Organization report.

To try to curb its spread, France, Germany and Austria have re-introduced tighter rules on arrivals from affected countries, including the United Kingdom.

UPDATE: What rules do European countries have in place for travel from the UK?

France has banned all non-essential travel from the UK following the surge in Indian variant coronavirus cases, as this strain now makes up over half of new cases in the UK.

“There is a new situation with the progression of the so-called Indian variant in the United Kingdom,” said government spokesman Gabriel Attal when announcing France’s tightened measures.

“Compelling reasons will be required for non-EU foreign nationals not resident in France joining France from the UK,” added the Foreign Ministry.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

France’s Covid-19 app to be ‘put to sleep’

France's Covid-tracker app, used for months for the all-important 'health pass' will be switched off today, health officials have confirmed.

France’s Covid-19 app to be 'put to sleep'

Covid-19 screening in France reaches an important milestone on Friday, June 30th, 2023 – when the TousAntiCovid app is officially ‘put to sleep’.

The app, which was launched in June 2020 as France came out of its first lockdown of the pandemic and has undergone a number of iterations, including as a delivery device for the health pass, will be switched off. 

For most people, this anniversary will pass without mention. Few people have consulted the app in recent months, and it has sat dormant on many smartphones since France’s Covid-19 health pass requirement was suspended in March 2022.

Meanwhile, the Système d’Informations de DEPistage (SI-DEP) interface – which has been informing people about their test results since the Spring of 2020 – is also being shut down on June 30th, as per legal requirements.

The SI-DEP shutdown means that it will also be impossible to retrieve Covid test certificates issued before June 30th, should the need arise. All data held by the database will be “destroyed”, officials have said.

It has handled more than 320 million antigen and PCR tests since it was introduced.

This does not mean that testing for Covid-19 has stopped, or is now unnecessary. As reported recently, more than 1,000 deaths a week in Europe are still caused by the virus.

The shutdown of the national information system does not mean that people in France cannot still book an appointment for an antigen test at a pharmacy, or a PCR test at a laboratory. But the number of people going for testing is declining rapidly. In recent days, according to Le Parisien, just 15,000 people in France took a Covid test – the lowest number, it said, since the pandemic started.

Reimbursement rules for testing changed on March 1st, with only certain categories of people – minors, those aged 65 and over, or immunosuppressed patients – covered for the entire cost of testing.

From Friday, only PCR test results will be transmitted to authorities for data purposes, meaning pharmacists that only offer antigen testing will be locked out of the online interface to record test results.

The reason for the shift in priorities is to maintain “minimal epidemiological surveillance”, the Ministry of Health has reportedly told scientists.

As a result test certificates, showing a positive or negative result, will no longer be issued from July 1st. Since February 1st, anyone taking a test has had to give consent to share their data in order to obtain a certificate. 

SHOW COMMENTS